國立高雄大學圖資館 |

Renal denervationtreatment and device-based neuromodulation /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Renal denervationedited by Richard R. Heuser ... [et al.].
其他題名:	treatment and device-based neuromodulation /
其他作者:	Heuser, Richard R.
出版者:	Cham :Springer International Publishing :2023.
面頁冊數:	xi, 256 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Renal hypertensionTreatment.
電子資源:	https://doi.org/10.1007/978-3-031-38934-4
ISBN:	9783031389344$q(electronic bk.)

Renal denervationtreatment and device-based neuromodulation /
Renal denervationtreatment and device-based neuromodulation /[electronic resource] :edited by Richard R. Heuser ... [et al.]. - Second edition. - Cham :Springer International Publishing :2023. - xi, 256 p. :ill., digital ;24 cm.

Pathophysiology: The Target for Renal Denervation -- Physiological Rationale for Renal Denervation Therapy in Hypertension -- Preclinical Model and Histopathology Translational Medicine and Renal Denervation -- Appraisal of the Clinical Trial Data on Renal Denervation for the Management of Resistant Hypertension -- Catheter-Based Technology Alternatives for Renal Denervation: An Overview -- Vincristine Local Delivery for Renal Artery Denervation -- Renal Denervation: Potential Future Implications Beyond Resistant Hypertension -- Renal Denervation for Congestive Heart Failure -- The Potential Role of Catheter-Based Renal Sympathetic Denervation in Chronic and End-Stage Kidney Disease -- Diabetes and Metabolic Syndrome -- Obstructive Sleep Apnea -- Future of Renal Denervation Studies and Clinical Implementation -- Transcatheter Carotid Body Denervation (Cibiem): First-in-Man Results and Future Directions -- Mobius for Hypertension: Results to Date and Pivotal Trial -- Sensing Renal Nerve Activity Before, During and After Denervation: Autonomix -- Sensing Renal Nerve Activity Before, During and After Denervation: SyMap -- Patient Selection for Renal Denervation Therapy - From Mild Hypertension in the Young -- Is There an Unmet Need for Device Treatment for Moderate Hypertension? -- What are the FDA Parameters for Pivotal Successful Study Design for Device Approval for Hypertension Therapy? -- What are the FDA Parameters for Pivotal Successful Study Design for Device Approval for Hypertension Therapy? -- US Preventive Services Task Force Recommendation on ABPM Rationale/Potential Implications: How Much Reduction of Blood Pressure is Enough? -- Renal Denervation Cost Analysis and Consideration -- What Needs to Be Shown Before Renal Denervation Can Be Used in Clinical Practice? -- How to Screen Patients for Renal Denervation Trials? Why Is There US Apathy Toward ABPM: Low Reimbursement or Cognitive Dissonance? -- Renal Denervation: New Data From the Latest Feasibility Trials -- Evaluation of the Renal Nerve: Anatomy, Renal Nerve Distribution and Animal Models -- Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis -- Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: Radiance-Htn Solo -- Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have been Learned -- Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program -- Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remain Unproven.

This extensively revised edition examines renal pathophysiology and the rationale for renal denervation for the management of hypertension, as well as possible long-term benefits and risks of this therapy. Renal denervation is a minimally invasive, endovascular catheter-based procedure that makes use of radiofrequency ablation to treat resistant hypertension, with studies showing a high degree of effectiveness. The devices involved in the continued evolution of this therapy are discussed and the book incorporates analyses of the development of the technique while evaluating its cost effectiveness and future applications. Renal Denervation: A New Approach to Treatment of Resistant Hypertension describes the technique in detail, its advances and its pitfalls. While it has been estimated that 50% of Western civilization has hypertension and approximately 20% of patients have resistant hypertension, hypertension remains the leading cause of cardiovascular morbidity and mortality thus strengthening arguments to consider a wider range of potential solutions to manage these patients.

ISBN: 9783031389344$q(electronic bk.)

Standard No.: 10.1007/978-3-031-38934-4doiSubjects--Topical Terms:

504539
Renal hypertension
--Treatment.

LC Class. No.: RC918.R38

Dewey Class. No.: 616.132

Renal denervationtreatment and device-based neuromodulation /
LDR:04701nmm a2200361 a 4500 001 654885
003 DE-He213
005 20240123182112.0
006 m d
007 cr nn 008maaau
008 240524s2023 sz s 0 eng d
020 $a 9783031389344$q(electronic bk.)
020 $a 9783031389337$q(paper)
024 7 $a 10.1007/978-3-031-38934-4 $2 doi
035 $a 978-3-031-38934-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC918.R38
072 7 $a MJ $2 bicssc
072 7 $a MJ $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJ $2 thema
072 7 $a MJ $2 thema
082 0 4 $a 616.132 $2 23
090 $a RC918.R38 $b R393 2023
245 0 0 $a Renal denervation $h [electronic resource] : $b treatment and device-based neuromodulation / $c edited by Richard R. Heuser ... [et al.].
250 $a Second edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xi, 256 p. : $b ill., digital ; $c 24 cm.
505 0 $a Pathophysiology: The Target for Renal Denervation -- Physiological Rationale for Renal Denervation Therapy in Hypertension -- Preclinical Model and Histopathology Translational Medicine and Renal Denervation -- Appraisal of the Clinical Trial Data on Renal Denervation for the Management of Resistant Hypertension -- Catheter-Based Technology Alternatives for Renal Denervation: An Overview -- Vincristine Local Delivery for Renal Artery Denervation -- Renal Denervation: Potential Future Implications Beyond Resistant Hypertension -- Renal Denervation for Congestive Heart Failure -- The Potential Role of Catheter-Based Renal Sympathetic Denervation in Chronic and End-Stage Kidney Disease -- Diabetes and Metabolic Syndrome -- Obstructive Sleep Apnea -- Future of Renal Denervation Studies and Clinical Implementation -- Transcatheter Carotid Body Denervation (Cibiem): First-in-Man Results and Future Directions -- Mobius for Hypertension: Results to Date and Pivotal Trial -- Sensing Renal Nerve Activity Before, During and After Denervation: Autonomix -- Sensing Renal Nerve Activity Before, During and After Denervation: SyMap -- Patient Selection for Renal Denervation Therapy - From Mild Hypertension in the Young -- Is There an Unmet Need for Device Treatment for Moderate Hypertension? -- What are the FDA Parameters for Pivotal Successful Study Design for Device Approval for Hypertension Therapy? -- What are the FDA Parameters for Pivotal Successful Study Design for Device Approval for Hypertension Therapy? -- US Preventive Services Task Force Recommendation on ABPM Rationale/Potential Implications: How Much Reduction of Blood Pressure is Enough? -- Renal Denervation Cost Analysis and Consideration -- What Needs to Be Shown Before Renal Denervation Can Be Used in Clinical Practice? -- How to Screen Patients for Renal Denervation Trials? Why Is There US Apathy Toward ABPM: Low Reimbursement or Cognitive Dissonance? -- Renal Denervation: New Data From the Latest Feasibility Trials -- Evaluation of the Renal Nerve: Anatomy, Renal Nerve Distribution and Animal Models -- Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis -- Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: Radiance-Htn Solo -- Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have been Learned -- Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program -- Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remain Unproven.
520 $a This extensively revised edition examines renal pathophysiology and the rationale for renal denervation for the management of hypertension, as well as possible long-term benefits and risks of this therapy. Renal denervation is a minimally invasive, endovascular catheter-based procedure that makes use of radiofrequency ablation to treat resistant hypertension, with studies showing a high degree of effectiveness. The devices involved in the continued evolution of this therapy are discussed and the book incorporates analyses of the development of the technique while evaluating its cost effectiveness and future applications. Renal Denervation: A New Approach to Treatment of Resistant Hypertension describes the technique in detail, its advances and its pitfalls. While it has been estimated that 50% of Western civilization has hypertension and approximately 20% of patients have resistant hypertension, hypertension remains the leading cause of cardiovascular morbidity and mortality thus strengthening arguments to consider a wider range of potential solutions to manage these patients.
650 0 $a Renal hypertension $x Treatment. $3 504539
650 0 $a Denervation. $3 965942
650 1 4 $a Internal Medicine. $3 273839
650 2 4 $a Radiology. $3 188995
700 1 $a Heuser, Richard R. $3 520586
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-38934-4
950 $a Medicine (SpringerNature-11650)